Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Novartis Ag
Relationship:   10% Owner
City:   Basel Switzerland
State:   V8
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   49,437,478    

Indirect Shares

   22,159,174      
Direct Value   $488,311,728    

Indirect Value

   $316,340,044      
Total Shares   71,596,652      
Total Value   $804,651,772      


Adhera Therapeutics, Inc $0 Eledon Pharmaceuticals Ord Shs $12,896,224 Kineta Ord Shs $805,730 Aeglea Biotherapeutics, Inc. $1,306,711 Intellia Therapeutics, Inc. $96,020,245 Q32 Bio Inc $51,855,721 Ra Pharmaceuticals, Inc. $105,728,421 Surface Oncology, Inc. $4,224,876 Aileron Therapeutics Inc $6,508,503 Bicycle Therapeutics Ltd $0 Galera Therapeutics, Inc. $357,854 Poseida Therapeutics, Inc. $15,656,436 Cellular Biomedicine Group Inc $28,800,576 Precision Biosciences Inc $164,150,431 Adhera Therapeutics, Inc $0 Eledon Pharmaceuticals Ord Shs $12,896,224 Kineta Ord Shs $805,730 Aeglea Biotherapeutics, Inc. $1,306,711 Intellia Therapeutics, Inc. $96,020,245 Q32 Bio Inc $51,855,721 Ra Pharmaceuticals, Inc. $105,728,421 Surface Oncology, Inc. $4,224,876 Aileron Therapeutics Inc $6,508,503 Bicycle Therapeutics Ltd $0 Galera Therapeutics, Inc. $357,854 Poseida Therapeutics, Inc. $15,656,436 Cellular Biomedicine Group Inc $28,800,576 Precision Biosciences Inc $164,150,431
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    14    

     Stock price went up :
    0   
    14    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   14.0   
     Percentage Gain/Loss :
     0.0%
 273.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Momenta Pharmaceuticals Inc MNTA 10% Owner 0 2006-07-25 4,708,679    Premium*  
            Adhera Therapeutics, Inc ATRX 10% Owner 2011-01-26 2,495,065 0    Premium*  
            Idenix Pharmaceuticals Inc IDIX 10% Owner 2014-08-05 0 2014-08-05 0    Premium*  
            Eledon Pharmaceuticals Ord Shs ELDN 10% Owner 2015-07-15 4,493,458 2014-09-22 0    Premium*  
            Kineta Ord Shs KA 10% Owner 2016-02-17 1,873,791 2016-02-17 0    Premium*  
            Aeglea Biotherapeutics, Inc. AGLE 2018-05-11 2,175,314 2016-04-12 0    Premium*  
            Intellia Therapeutics, Inc. NTLA 10% Owner 2017-12-12 4,129,903 2016-05-11 0    Premium*  
            Q32 Bio Inc QTTB 10% Owner 2018-04-02 1,979,226 2018-04-02 0    Premium*  
            Ra Pharmaceuticals, Inc. RARX 10% Owner 2017-06-19 2,251,457 2016-10-31 0    Premium*  
            Aadi Bioscience, Inc AADI 10% Owner 2017-03-15 0 2019-04-26 4,049,804    Premium*  
            Altimmune, Inc ALT 10% Owner 0 2018-09-12 8,345,145    Premium*  
            Surface Oncology, Inc. SURF 10% Owner 2018-04-23 3,948,482 2018-04-23 0    Premium*  
            Aileron Therapeutics Inc ALRN 10% Owner 2019-04-01 2,079,394 2018-07-16 0    Premium*  
            Bicycle Therapeutics Ltd BCYC 10% Owner 2019-05-28 1,769,641 2019-05-28 0    Premium*  
            Galera Therapeutics, Inc. GRTX Former 10% Owner 2020-06-19 2,467,961 2019-11-12 3,543,067    Premium*  
            Forma Therapeutics Holdings, Inc., FMTX 10% Owner 0 2020-06-18 331,221    Premium*  
            Akouos, Inc. AKUS Former 10% Owner 2020-06-30 0 2020-06-30 1,181,258    Premium*  
            Poseida Therapeutics, Inc. PSTX 10% Owner 2020-07-14 5,908,089 2020-07-14 0    Premium*  
            Cellular Biomedicine Group Inc CBMG 10% Owner 2020-08-11 1,458,257 0    Premium*  
            Precision Biosciences Inc DTIL 10% Owner 2022-06-15 12,407,440 0    Premium*  
* Premium Members only  

Records found :    152         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-06-05 4 S $23.11 $110,488 D/D (4,780) 2,320,691 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-06-06 4 S $22.98 $167,161 D/D (7,274) 2,313,417 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-06-07 4 S $22.11 $106,999 D/D (4,840) 2,308,577 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-06-08 4 S $22.00 $15,400 D/D (700) 2,307,877 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-06-16 4 S $21.24 $1,130,207 D/D (53,200) 2,254,677 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-06-19 4 S $22.02 $70,899 D/D (3,220) 2,251,457 0 -
ALT Altimmune, Inc 10% Owner   –       –       •   2017-11-14 4 A $0.00 $0 I/I 182,262 2,049,563 0 -
NTLA Intellia Therapeutics, In... 10% Owner   –       –       •   2017-12-12 4 S $18.30 $27,870,900 D/D (1,523,000) 4,129,903 0 -
ALT Altimmune, Inc 10% Owner   –       –       •   2017-12-13 4 A $0.00 $0 I/I 242,694 2,292,257 0 -
ALT Altimmune, Inc 10% Owner   –       –       •   2017-12-15 4 A $0.00 $0 I/I 65,718 2,357,975 0 -
ALT Altimmune, Inc 10% Owner   –       –       •   2018-01-17 4 A $0.00 $0 I/I 176,586 2,534,561 0 -
ALT Altimmune, Inc 10% Owner   –       –       •   2018-02-13 4 A $0.00 $0 I/I 269,527 2,804,088 0 -
ALT Altimmune, Inc 10% Owner   –       –       •   2018-02-15 4 A $0.00 $0 I/I 67,925 2,872,013 0 -
ALT Altimmune, Inc 10% Owner   –       –       •   2018-03-15 4 A $0.00 $0 I/I 261,969 3,133,982 0 -
QTTB Q32 Bio Inc 10% Owner   –       –       •   2018-04-02 4 A $0.00 $0 D/D 1,979,226 1,979,226 0 -
ALT Altimmune, Inc 10% Owner   –       –       •   2018-04-16 4 A $0.00 $0 I/I 700,066 3,834,048 0 -
SURF Surface Oncology, Inc. 10% Owner   –       –       •   2018-04-23 4 A $0.00 $0 D/D 3,181,816 3,181,816 0 -
SURF Surface Oncology, Inc. 10% Owner   –       –       •   2018-04-23 4 B $15.00 $11,499,990 D/D 766,666 3,948,482 2.45 -
AGLE Aeglea Biotherapeutics, I...   •       •       •   2018-05-07 4 S $10.11 $157,190 D/D (15,548) 2,295,376 0 -
AGLE Aeglea Biotherapeutics, I...   •       •       •   2018-05-08 4 S $10.03 $266,367 D/D (26,557) 2,268,819 0 -
AGLE Aeglea Biotherapeutics, I...   •       •       •   2018-05-09 4 S $10.11 $517,935 D/D (51,230) 2,217,589 0 -
AGLE Aeglea Biotherapeutics, I...   •       •       •   2018-05-10 4 S $10.13 $230,204 D/D (22,725) 2,194,864 0 -
AGLE Aeglea Biotherapeutics, I...   •       •       •   2018-05-11 4 S $10.06 $196,673 D/D (19,550) 2,175,314 0 -
ALT Altimmune, Inc 10% Owner   –       –       •   2018-05-15 4 A $0.00 $0 I/I 274,703 4,108,751 0 -
ALT Altimmune, Inc 10% Owner   –       –       •   2018-05-16 4 A $0.00 $0 I/I 767,728 4,876,479 0 -
  152  Records found
  1   2   3  4   5   6   7      
  Page 3 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us